Tumor Necrosis Factor, Tuberculosis, Testing, and Treatment: Teeing Up the Questions

Authors

  • Kenneth G. Saag,

    Corresponding author
    1. University of Alabama at, Birmingham
    • University of Alabama at Birmingham, 1720 2nd Avenue South, Birmingham, AL 35294. E-mail: Ksaag@uab.edu

    Search for more papers by this author
    • Dr. Saag has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from Roche, BMS, and Amgen.

  • Kevin Winthrop,

    1. Oregon Health and Sciences University, Portland
    Search for more papers by this author
    • Dr. Winthrop has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from UCB, Genentech, Abbott, and Regeneron, and (more than $10,000) from Pfizer.

  • Jeffrey R. Curtis

    1. University of Alabama at, Birmingham
    Search for more papers by this author
    • Dr. Curtis has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from Pfizer, BMS, Crescendo, and AbbVie, and (more than $10,000 each) from Roche/Genentech, UCB, Janssen, the Consortium of Rheumatology Researchers of North America, and Amgen.


No abstract is available for this article.

Ancillary